PBSV

$0.52+0.00%

Pharma-Bio Serv, Inc.

Market Cap

$12M

Live price × SEC shares (Sep 10, 2026)

Sector

Health Care

Industry

Life Sciences Tools & Services

Beta (raw)

0.68

60mo monthly vs SPY

P/E (TTM)

52.0

TTM to Jul 2026 · diluted EPS

P/S (TTM)

1.3

TTM to Jul 2026 · revenue

P/B

1.1

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q4 FY2025 Oct 31, 2025	Q1 FY2026 Jan 31, 2026	Q2 FY2026 Apr 30, 2026	Q3 FY2026 Jul 31, 2026	TTM Jul 31, 2026
Revenue	2,150	2,295	2,703	2,336	9,484
Cost of revenue	1,401	1,573	1,801	1,644	6,419
Gross profit	749	722	902	692	3,065
Selling, general & administrative	882	817	757	764	3,220
Operating income	(133)	(95)	145	(72)	(155)
Pretax income	4	36	239	(11)	269
Income tax	4.4	3.6	6.4	3.1	17.5
Net income	0	33	233	(14)	252
EPS (diluted) ($)		0.00	0.01	0.00	0.01
Weighted avg. shares (basic)		22,906	22,902	22,902
Weighted avg. shares (diluted)		22,913	22,912	22,911

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Sep 14, 2026, period ended Jul 31, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jul 2010, with Tormere Pro.

Corporate Events (8-K)

5 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Sep 14, 2026 accepted 5:22 PM ET	2.02Earnings release	Document SEC ↗
Jun 15, 2026 accepted 5:06 PM ET	2.02Earnings release	Document SEC ↗
May 15, 2026 accepted 5:02 PM ET	5.07Shareholder vote	Document SEC ↗
Mar 17, 2026 accepted 5:19 PM ET	2.02Earnings release	Document SEC ↗
Jan 29, 2026 accepted 5:07 PM ET	2.02Earnings release	Document SEC ↗
Sep 15, 2025 accepted 5:27 PM ET	2.02Earnings release	Document SEC ↗
Jun 16, 2025 accepted 4:30 PM ET	2.02Earnings release	Document SEC ↗
May 16, 2025 accepted 5:03 PM ET	5.07Shareholder vote	Document SEC ↗
Mar 17, 2025 accepted 5:18 PM ET	2.02Earnings release	Document SEC ↗
Jan 29, 2025 accepted 5:01 PM ET	2.02Earnings release	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

—

of daily vol

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

No Form 4 transactions on record.

Recent News

Pharma-Bio Serv Inc (OTC: PBSV) Share Price, PBSV Stock News, PBSV Share Price & Updates

Kalkine · 2026-11-03

Pharma-Bio Serv, Inc. (PBSV) Seasonal Returns Chart - Yahoo Finance

Yahoo! Finance Canada · 2026-10-31

PBSV Changes Proving to be Beneficial to Business

Yahoo Finance · 2026-09-15

Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2026

Yahoo Finance · 2026-09-14

PBSV is a Small Stock Worth a Look

Yahoo Finance · 2026-06-16

Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2026

Yahoo Finance · 2026-06-15

Wall Street holds steadier as AI stocks recover some of last week's sell-off

PBS · 2026-06-08

The 7 Best Penny Stocks Under $1 to Buy Now

InvestorPlace · 2022-12-20

Productive Business Solutions (JMSE:PBS) - Stock Analysis

Simply Wall St · 2020-01-03

6 factors that fueled the stock market dive in 2018

PBS · 2018-12-27

Pharma-Bio Serv, Inc. (PBSV) Stock Price, News, Quote & History

Yahoo! Finance Canada · 2017-06-08

Informational purposes only, not investment advice.

Corporate Events (8-K)

5 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Sep 14, 2026 accepted 5:22 PM ET	2.02Earnings release	Document SEC ↗
Jun 15, 2026 accepted 5:06 PM ET	2.02Earnings release	Document SEC ↗
May 15, 2026 accepted 5:02 PM ET	5.07Shareholder vote	Document SEC ↗
Mar 17, 2026 accepted 5:19 PM ET	2.02Earnings release	Document SEC ↗
Jan 29, 2026 accepted 5:07 PM ET	2.02Earnings release	Document SEC ↗
Sep 15, 2025 accepted 5:27 PM ET	2.02Earnings release	Document SEC ↗
Jun 16, 2025 accepted 4:30 PM ET	2.02Earnings release	Document SEC ↗
May 16, 2025 accepted 5:03 PM ET	5.07Shareholder vote	Document SEC ↗
Mar 17, 2025 accepted 5:18 PM ET	2.02Earnings release	Document SEC ↗
Jan 29, 2025 accepted 5:01 PM ET	2.02Earnings release	Document SEC ↗